Hi Gabor ..So last 2 weeks of Feb 2016 ..for sure !
Sorry , do not think you can be that exact . At the start of enrollment you had mostly US patients with a starting TG level of 150. End of 2013 you had the TG level moved up to 200 to qualify and a push into recruiting from Eastern Europe where the event rate per population is higher .
So I would expect a lower event rate per population 2012-2013 and a higher event rate for those enrolled after 2013
So you are saying ...possible event rate of 4.9% with 19.5 % efficacy will be enough for P .001 and stop the trial